Home / Stocks / RGLS

RGLS insider trading

Regulus Therapeutics Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$171k
Buys · last 90 days
0 · $0
Most recent buy
2025-06-04

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-06-04Klassen Preston
President & Head of R & D
Bought12,000$7.99$96k
2025-01-31Hagan Joseph P
Chief Executive Officer
Bought50,000$1.09$54k
2025-01-31BALTIMORE DAVID
Director
Bought19,610$1.06$21k

Most active insider buyers

InsiderRoleBuysTotal bought
Klassen PrestonPresident & Head of R & D1$96k
Hagan Joseph PChief Executive Officer1$54k
BALTIMORE DAVIDDirector1$21k

See RGLS on the chart

Every insider buy and sell for RGLS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.